MEDISCA Australia | Essential Elements of Personalised Analgesic Medications - Pain (Doctors) | On-demand
Analgesic therapies present particular issues and challenges to the physicians and pharmacists. The practice-based activity will provide general practitioners and pharmacists with the opportunity to enhance their competency as it relates to the many therapeutic options used in analgesic therapies. Having been presented with a prescription indicating a need for a medication, the participants will use uniquely designed patient assessment tools, select appropriate delivery systems for the specific analgesics and nutritional supplements prescribed, and then monitor patient progress.
During this process the participants will have learned how to relate drug mechanisms of action to physiological and pathophysiological pathways responsible for the elicitation of a pain response, how to conduct a patient needs analysis and then work collaboratively to provide expertise with respect to the therapeutic, concomitant adjuvant, and lifestyle and behavior modification options available to the physician.
Finally, participants will apply monitoring tools and strategies to maintain patient compliance with prescribed analgesic initiatives. Case work will be documented and clinical findings recorded in a formal manner for purposes of confidential communication, record keeping and statistical analysis.
- Employ customised principles and techniques of analgesic formulation-related delivery systems.
- Identify and develop novel targeting approaches to physiological and pathophysiological pathways.
- Relate physiological and biochemical features of signal transmission and transduction.
- Interpret deleterious signal elicitation and subsequent excitation, inhibition, cessation and modulation though analgesic therapy.
- Assess the various routes of delivery, delivery systems, dosage forms and dispensing mechanisms used in analgesic therapy, adjunct therapy, supplementation and specific aspects of lifestyle management.
- Evaluate and select therapeutic alternatives for specific classifications related to analgesic therapy; specifically formulations which may be prescribed or used by the physician in the treatment of nociception, neuropathology, neuromas, centralisation, direct and indirect consequences of vascular deprivation, neural budding and plasticity.
- Review comprehensive patient assessment chart data; includes prior medical history, familial history, differential diagnoses, lifestyle behaviors, signs and symptoms, laboratory test results, and analgesic-related medication, adjunct pharmacotherapeutic and supplementation treatments. Interpret and apply this resource.
This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.
The activity workbook is copyright © 2017-2020 LP3 Network
Google Chrome (most recent 2 versions)
Mozilla Firefox (most recent 2 versions)
Internet Explorer v11
Apple Safari (most recent 2 versions)
Microsoft Edge (most recent 2 versions)
Computer: 1 Mbps or better (broadband recommended)
Mobile device: 3G or better (WiFi recommended for VoIP audio)
No additional software needed
|2GB of RAM (minimum), 4GB or more of RAM (recommended)|
|MIGUEL DE LA GARZA, MD, DABA, DAPM|
Diplomate, American Board of Anesthesiology; Diplomate, American Board of Pain Medicine; Facilitator, LP3 Network
Dr. de la Garza is a board certified physician who practices multidisciplinary interventional pain management in four offices in the Tampa Bay area. He performs interventional pain procedures, specializing in minimally invasive surgical decompression of herniated discs and spinal stenosis, implantable intrathecal pumps, spinal cord stimulation, and peripheral nerve stimulation. Dr. de la Garza has published numerous research papers and abstracts, and has presented at regional and national academic conferences on the topics of anesthesia and pain medicine. He is also a consultant for numerous pharmaceutical and medical device manufacturers.
Dr. de la Garza received a Bachelor of Science in Molecular Biology and a Bachelor of Arts in Chemistry from Texas Lutheran College in Seguin, Texas. He graduated from the University of Texas Southwestern Medical School in 2001 and performed his anesthesia residency at the University of South Florida College of Medicine, Department of Anesthesiology and Critical Care from 2001 to 2005. He then completed an interventional pain medicine fellowship at The Cleveland Clinic, in the Department of Anesthesia and Pain Management.
|KEN SPEIDEL, BS Pharm, PharmD, RPh, FIACP, FACA|
Facilitator, LP3 Network; Vice President, Compounding Compliance, Gates Healthcare Associates; Surveyor and Accreditation Expert, Accreditation Commission for Health Care (ACHC/PCAB); Fellow, International Academy of Compounding Pharmacists (IACP); Fellow, American College of Apothecaries (ACA); Professor of Pharmacy Practice (retired), University of Findlay.
Dr. Ken Speidel is recognized for his broad experience in pharmacy practice and education, including his national recognition as a pharmacotherapeutic specialist in endocrinology and pain management. In addition, Dr. Speidel provides expert training in sterile and non-sterile compounding processes in the acute care, community, outpatient, and 503A/503B practice sectors. He has been instrumental in the development of national standards for pharmacy compounding practices and provides consulting services to many organizations including boards of pharmacy as well as hospitals and health systems in the United States and abroad.
In addition to his worldwide consulting and educational work, Dr. Speidel is a retired Professor of Pharmacy Practice from the University of Findlay. He has also assisted in the development and facilitation of many nationally recognized educational programs, approved by the Accreditation Council for Pharmacy Education (ACPE). Moreover, Dr. Speidel was an advisor for the development of the Pharmacy Compounding Accreditation Board (PCAB) and remains a surveyor and accreditation expert for PCAB/ACHC (Accreditation Commission for Health Care). Dr. Speidel has served as multi-term president of the National Home Infusion Association (NHIA) as well as president of the Hospice of Portage, a large hospice program in the United States.
Dr. Speidel received a Bachelor of Science and Doctor of Pharmacy from Ohio Northern University and has completed postdoctoral training in nutritional support and functional medicine. He has been awarded Fellowship status with the International Academy of Compounding Pharmacists (IACP) as well as the American College of Apothecaries (ACA).
|SHANNON BELLEVUE, BSc, MSc|
Medical Editor Team Lead
CANCELLATION AND REFUND POLICY:
There are no refunds, returns or transfer upon purchase of the on-demand activity.